References
- Banskota AH, Tezuka Y, Adnyana IK, Xiong Q, Hase K, Kadota S (2000): Hepatoprotective effect of Combretum quadran-gulare and its constituents. Biol Pharm Bull 23: 456–460.
- Basnet P, Kadota S, Shimazu M, Namba T (1994): Bellidifolin: a potent hypoglycemic agent in streptozotocin (STZ)-induced diabetic rats from Swertia japonica. Planta Medi 60: 507–511.
- Born SL, Caudill D, Smith BJ, Lehman-McKeeman LD (2000): In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity Toxicol Sci 58: 23–31.
- Bowers GN, McComb RB (1966): A continuos spectrophoto-metric method for measuring the activity of serum phos-phatase. Clin Chem 12: 70–73.
- Braga R (1976): Plantas do Nordeste especialmente do Ceath, 3th ed. pp. 219. Imprensa Oficial, Fortaleza, Brasil.
- Bravo BJA, Sauvain M, Massiot, Gimenez A, Munoz V, Callapa J, Men-Olivier LL, Massiot G, Lavaud C (1999): Bioactive phenolic glycosides from Amburana cearensis. Phyto-chemistry 50: 71–74.
- Canuto KM, Silveira ER (2000): Flavonóides de Amburana cearensis (Fr. All.) A. C. Smith (CUMARU). In: XV/ Sim-posio de Plantas Medicinais do Brasil. Recife, Pernam-buco, Brazil.
- Canuto KM, Silveira ER (1998): Estudo quimico de Torresea cearensis Fr. All.(cumaru). In: XV Simposio de Plantas Medicinais do Brasil. Aguas de Lindóia, Sao Paulo, Brazil.
- Carlton BD, Aubrun JC, Simon GS (1996): Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and Cd-1 mice. Fund Appl Toxicol 30: 145–151.
- Casley-Smith JR, Morgan RG, Piller NB (1993): Treatment of lymphedema of the arms and legs with 5,6-benzo(alpha)-pyrone. New Engl J Med 329: 1158–1163.
- Chung MI, Gan KH, Lin CN, Ko FN, Teng CM (1993): Antiplatelet effects and vasorelaxing action of some con-stituents of Formosan plants. J Nat Prod 56: 929–934.
- Cohen AJ (1979): Critical review of the toxicology of coumarin with special reference to interspecies differences in metab-olism and hepatotoxic response and their significance to man. Food Cosmet Toxicol 17: 277–289.
- Correa PM (1984): Dicionário de plantas iiteis do Brasil e das exóticas cultivadas, vol 2, pp. 474–475, Ministério da Agricultura, Brasilia.
- De Meyer N, Haemers A, Mishra L, Berghe V, Vlietinck AJ (1991): 4'-Hydroxy-3-methoxyflavones with potent antipi-cornavirus activity. J Med Chem 34: 736–746.
- Drabkin DL, Austin JH (1932): Spectrophotometric studies, I. spectrophotometric constants for commons hemoglobin derivates in human, dog and rabbit blood. J Biol Chem 177: 751–756.
- Edwards AJ, Price RJ, Renwick AB, Lake BG (2000): Lack of effect of coumarin on unscheduled DNA synthesis in the in vivo rat hepatocyte DNA repair assay. Food Chem Toxicol 38: 403–409.
- Evans JG, Appleby EC, Lake BG, Conning DM (1989): Studies on the induction of cholangiofibrosis by coumarin in the rat. Toxicology 55: 207–224.
- Fernandez-Salguero P, Hoffinan SM, Cholerton S, Mohren-weiser H, Raunio H, Rautio A, Pelkonen O, Huang JD,
- Evans WE, Idle JR (1995): A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 57: 651–660.
- Gangolli SD, Shilling WH, Grasso P, Gaunt IF (1974): Studies on the metabolism and hepatotoxicity of coumarin in the baboon. Biochem Soc Trans 2: 310–312.
- Gartner BC, Seifert CB, Michalk DV, Roth B (1993): Phenpro-coumon therapy during pregnancy: case report and com-parison of the teratogenic risk of different coumarin derivates. Z Geburtshilfe Perinatol 197: 262–265.
- Gullsten H, Agundez JA, Benitez J, Laara E, Ladero JM, Diaz-Rub Fernadez Salguero P, Gonzalez F, rautio A, Pelkonen O, Raunio D (1997): CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis. Pharmacogenetics 7: 247–250.
- Gutmann L, Bergmeyer HU (1974): Methods of Enzymatic Analysis. 2nd ed, pp. 214-216. Verlag Chemie, Academic Press, Washington.
- Haworth S, Lawlor T, Mortelmans K, Speck W, Zeiger E (1983): Salmonella mutagenicity test results for 250 chemicals. Environ Mutagen 5 (suppl. 1): 3–142.
- Henry RJ, Cannon DC, Winkelman JW (1974): Clinical Chem-istry: Principles and Techiniques, 2nd ed, pp. 110–120. Harper & Row, New York.
- Henry RJ, Chiamori N, Golub OJ, Berkman S (1960): Revised spectrophotometric methods for the determination of glu-tamic-oxaloacetic transaminase, glutamic-pyruvic transam-inase and lactic acid dehydrogenase. Am J Clin Pathol 34: 381–385.
- Henry JB (1996): Clinical Diagnosis and Management by Laboratory Methods. W.B. Saunders Compant 19th, chapter 13, pp. 279; 280–281, New York.
- Hoult JRS, Paya. M (1996): Pharmacological and biochemical actions of simple coumarins: natural products with thera-peutic potential. Gen Pharmacol 27: 713–722.
- Kuster RM, Rocha LM (1999): Farmacognosia-da planta medi-cinal ao medicamento. 1st Ed, chapter 21, Cumarinas, Cromonas e Xantonas, pp. 451. Ed UFSC, Florianópolis, Brasil.
- Lake BG (1999): Coumarin metabolism, toxicity and carcino-genicity: relevance for human risk assessment. Food Chem Toxicol 37: 423–453.
- Leal LKAM, Ferreira AAG, Bezerra GA, Matos FJA, Viana GSB (2000): Antinociceptive, anti-inflammatory and bron-chodilator activities of Brazilian medicinal plants contain-ing coumarin: a comparative study. J Ethnopharmacol 70: 151–159.
- Leal LKAM, Matos ME, Matos FJA, Ribeiro RA, Ferreira FV, Viana GSB (1997): Antinociceptive and antiedemato-genic effects of the hydroalcoholic extract and coumarin from Torresea cearensis Fr. All. Phytomedicine 4: 221–227.
- Lin CN, Hsieh HK, Liou SJ, Ko HH, Lin HC, Chung MI, Ko FN, Liu HW, Teng CM (1996a): Synthesis and antithrom-botic effect of xanthone derivates. J Pharm Pharmacol 48: 887–890.
- Lin CN, Liou SJ, Lee TH, Chuang YC, Won SJ (1996b): Xan-thones derivaties as potential anti-cancer drugs. J Pharm Pharmacol 48: 539–544.
- Loprinzi CL, Kugler JAW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H (1999): Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340: 346–350.
- Martin-AragOn S, Benedi J, Villar A (1996): Oxygen active species-scavenger properties of coumarins. Phytother Res 10: 575–578.
- Neuhaus-Carlisle K, Vierling W, Wagner H (1997): Screening of plant extracts and plant constituents for calcium-channel blocking activity. Phytomedicine 4: 67–69.
- NTP (1993): Toxicology and carcinogenesis studies of coumarin (Cas No. 91-64-5) in F344/N rats and B6C3F1 mice (gavage studies). National Toxicology Program. Technical Report No. 93–3153. US Department of Health and Human Services, NIH, Research triangle Park, NC.
- Opdyke DLJ (1974): Monographs on fragrance raw materials: Coumarin. Fd Cosmet. Toxicol 12: 385.
- Reynolds JEF (1996): Martindale: The Extra Pharmacopoeia. 30 ed, Pharmaceutical Press, London.
- Robbers JE, Tyler VE, Speedie MR (1997): Farmacognosia e Farmacobiotecnologia. Chapter 8, FenilpropanOides, pp. 153–155, Ed Premier, Sao Paulo, Brasil.
- Rocha D (1945): Formulário Therapeutico de Plantas Medici-
- nais Cearenses Nativas e Cultivadas, pp. 45, Ed Progresso, Fortaleza, Brasil.
- Shilling WH, Crampton RF, Longland RC (1969). Metabolism of coumarin in man. Nature 221: 664–665.
- SoMe TO (1964): Naturally occurring coumarins and related physiological activities. Pharm Sci 53: 231–264.
- Struwe FE, Reinwein H, Stier R (1984): Coumarin embryopa-thy. Radiologe 24: 68–71.
- Tanaka AS, Sampaio MU, Marangoni S, de Oliveira B, Novello JC, Oliva ML, Fink E, Sampaio CA (1997): Purification and primary structure determination of a Bowman-Birk trypsin inhibitor from Torresea cearensis seeds. J Biol Chem 378: 273–281.
- Trinder P (1969): Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6: 24–25.
- WangY, Hamburger M, Gueho J, Hostettmam K (1989): Antimi-crobial flavonoids from Psidia trinervia and their methy-lated and acetylated derivatives. Phytochemistry 28: 2323–2327.
- Williams WJ, Beutler E, Erslev AJ, Rundles RW (1976): Hemathologia. Guanabara Koogan, Rio de Janeiro, Brasil, pp. 58–70.
- Wintrobe MM (1981): Clinical Hematology. 8th ed, pp. 215–230. Lea & Fabinger, Philadelphia.
- Zipprich K, Canzler E, Hundsdorfer S (1987): Teratogenic effect of coumarins. Zentralbl Gynakol 109: 364–368.